Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 9 Osteosarcoma 4 Sarcoma, Ewing 3 Rhabdomyosarcoma 3 Neuroblastoma 3 Neoplasms 3 Medulloblastoma 3 Glioma 3 Ependymoma 3 Central Nervous System Neoplasms 3 Carcinosarcoma 3 Wilms Tumor 2 Rhabdoid Tumor 2 Recurrence 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasm Metastasis 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioblastoma 2 Endometrial Neoplasms 2 Carcinoma, Endometrioid 2 Breast Neoplasms 2 Xanthogranuloma, Juvenile 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Sarcoma, Synovial 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Pathologic Complete Response 1

Interventions

Ibandronic Acid 8 Gemcitabine 8 Doxorubicin 6 Cyclophosphamide 6 Zoledronic Acid 5 Radiation 4 Nivolumab 4 Irinotecan 4 pembrolizumab 3 Vincristine 3 Temozolomide 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Denosumab 3 Cisplatin 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3 regorafenib 2 pegfilgrastim 2 Tranexamic Acid 2 Trabectedin 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiosurgery 2 Quality of Life 2 Proton Therapy 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Neoplasms × olaparib × Sarcoma × Clear all

NCT02398058 2021-04-14

TOMAS

Italian Sarcoma Group

Phase 1 Completed

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡